Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.

Detalles Bibliográficos
Publicado en:International Wound Journal Vol. 16; no. 4; pp. 1047 - 1049
Autores principales: Marasca, Claudio, Fontanella, Giuseppina, Annunziata, Maria C., Marasca, Dario, Fabbrocini, Gabriella
Formato: case study letter pictorial Journal Article
Publicado: Wiley-Blackwell Aug2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137639531&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137639531
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17424801
        1725
      jtl: International Wound Journal
      issn: 17424801
      maglogo: Y
    pubinfo:
      dt: Aug2019
      vid: 16
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        137639531
        137639531
        137639531
        10.1111/iwj.13123
        137639531
      ppf: 1047
      ppct: 2
      formats:
      tig:
        atl: Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.
      aug:
        au:
          Marasca, Claudio
          Fontanella, Giuseppina
          Annunziata, Maria C.
          Marasca, Dario
          Fabbrocini, Gabriella
        affil: Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples Italy
      sug:
        subj:
          Pyoderma Gangrenosum Symptoms
          Pyoderma Gangrenosum Diagnosis
          Pyoderma Gangrenosum Drug Therapy
          Male
          Middle Age
          Skin Ulcer Surgery
          Biopsy
          Hyperplasia Diagnosis
          Skin Ulcer Etiology
          Adalimumab Administration and Dosage
          Tacrolimus Administration and Dosage
          Administration, Topical
          Hematologic Tests
          Treatment Outcomes
          Middle Aged: 45-64 years
          Male
      pubtype: Academic Journal
      doctype:
        case study
        letter
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N